We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more
First quarter 2024 Total Revenue of $14.8 million, a year-over-year increase of 64%, and 7th consecutive quarter of >50% growth in Lung Diagnostic test volume; First quarter 2024 gross profit...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31...
Studies highlight advancements in technology to detect cell-free DNA and rapid turnaround time in a real-world clinical setting Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.32 | 26.0162601626 | 1.23 | 1.57 | 1.23 | 132297 | 1.47931344 | CS |
| 4 | 0.34 | 28.0991735537 | 1.21 | 1.57 | 1.15 | 75829 | 1.34386959 | CS |
| 12 | -0.08 | -4.90797546012 | 1.63 | 1.93 | 1.15 | 138022 | 1.41116103 | CS |
| 26 | 0.1 | 6.89655172414 | 1.45 | 2.21 | 1.15 | 125802 | 1.60269908 | CS |
| 52 | -0.04 | -2.51572327044 | 1.59 | 2.21 | 1.03 | 99675 | 1.54987584 | CS |
| 156 | -12.81 | -89.2061281337 | 14.36 | 16.395 | 0.955 | 166603 | 3.07180115 | CS |
| 260 | -12.04 | -88.5945548197 | 13.59 | 31.99 | 0.955 | 163295 | 5.06295281 | CS |
AJ Freely
10 months ago
1hot toddy
1 year ago
Leg58
1 year ago
Leg58
1 year ago
subslover
2 years ago
subslover
2 years ago
MiamiGent
2 years ago
carusso
2 years ago
crudeoil24
2 years ago
crudeoil24
2 years ago
crudeoil24
2 years ago
Leg58
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
